Mera Pharmaceuticals, Inc.
MRPI · OTC
10/31/2020 | 10/31/2011 | 10/31/2010 | 10/31/2009 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $4 | $6 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $8 | $9 | $7 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $42 | $0 | $16 |
| Total Curr. Assets | $0 | $54 | $15 | $26 |
| Property Plant & Equip (Net) | $0 | $2 | $8 | $200 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $14 | $51 | $31 |
| Total NC Assets | $0 | $16 | $59 | $232 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $71 | $73 | $257 |
| Liabilities | – | – | – | – |
| Payables | $0 | $486 | $374 | $164 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $175 | $30 |
| Other Curr. Liab. | $0 | $449 | $202 | $202 |
| Total Curr. Liab. | $0 | $935 | $750 | $397 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $0 | $935 | $750 | $397 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $55 | $55 | $55 |
| Retained Earnings | -$8 | -$8,886 | -$8,699 | -$8,161 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8 | $7,967 | $7,967 | $7,967 |
| Total Equity | -$0 | -$865 | -$677 | -$139 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $71 | $73 | $257 |
| Net Debt | $0 | -$4 | -$6 | -$3 |